3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Recruiting
14
Active not recruiting
11
Completed
3
Withdrawn
2
Terminated
1
Suspended
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
5
Prostatic Neoplasms
4
Lung Neoplasms
4
Breast Neoplasms
4
Neoplasm Metastasis
3
Multiple Myeloma
3
Melanoma
3
Carcinoma, Intraductal, Noninfiltrating
3
Brain Neoplasms
3
Urinary Bladder Neoplasms
2
Thrombocytosis
2
Stomach Neoplasms
2
Myeloproliferative Disorders
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Hematologic Neoplasms
2
Gastrointestinal Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Sarcoma, Kaposi
1
Sarcoma
1
Rhabdomyosarcoma
1
Resectable Pancreatic Carcinoma
1
Rectal Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Plasmacytoma
1
Interventions
Carboplatin
44
Paclitaxel
43
liposomal doxorubicin
23
Topotecan
19
Gemcitabine
18
pembrolizumab
17
Cyclophosphamide
17
Bevacizumab
16
Cisplatin
12
niraparib
9
olaparib
8
fludarabine
7
Taxes
7
Docetaxel
7
aldesleukin
6
Nivolumab
6
Doxorubicin
6
1-dodecylpyridoxal
6
oregovomab
5
fludarabine phosphate
5
Peripheral Blood Stem Cell Transplantation
5
Filgrastim
5
rucaparib
4
durvalumab
4
avelumab
4
Surgical Procedures, Operative
4
Melphalan
4
Ipilimumab
4
Interleukin-2
4
Etoposide
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Ovarian Neoplasms
×
Specimen Handling
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled